Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patient previously treated with CSII. - Hirsch,IB.; Bode,BW.; Garg,S.; Lane,WS.; Sussman,A.; Hu,P.; Santiago,OM.; Kolaczynski,JW. (Diabetes Care, 2005)